Ardan Equity

Ardan Equity is a private equity firm based in Palm Beach, Florida, established in 2018. It specializes exclusively in the healthcare and life sciences software and data sector. The firm collaborates closely with founders and management teams to accelerate growth and develop leading platforms in the market. Ardan's focus is on creating differentiated solutions across various healthcare segments, including life sciences, payers, providers, and employers. By leveraging proprietary growth strategies, a trusted network, and experienced executives, Ardan aims to deliver superior risk-adjusted performance while fostering innovation in healthcare software.

Drew Boston

Founding Partner

5 past transactions

MMIT

Private Equity Round in 2021
Formularies from P&T to point of care: MMIT brings transparency and guidance to pharmacy and medical benefit information. Payers, pharmaceutical companies, providers and pharmacies use our data and workflow app to provide clarity from P&T to the point of care, ensuring consistent managed care decisions across the healthcare market.

WellSky

Private Equity Round in 2020
WellSky is a provider of comprehensive software solutions and professional services designed for the healthcare and social services sectors. With over 25 years of experience, the company focuses on addressing the continuum of care by offering tools that facilitate collaboration among organizations and communities. WellSky's software supports a range of healthcare environments, including acute and non-acute care, and is used by healthcare providers, accountable care organizations, and government entities worldwide. The company's offerings aim to improve performance management, cost control, and quality of care, while also delivering predictive insights to help organizations navigate the complexities of their industries.

HealthEdge

Private Equity Round in 2020
HealthEdge is a technology company that provides an integrated software platform designed for healthcare payors. Founded in December 2004 by Albert Waxman and Rob Gillette, HealthEdge specializes in delivering innovative solutions that help health insurers enhance operational efficiency, improve patient outcomes, and significantly lower administrative costs. The company's flagship product suite, HealthRules, is built on patented technology and can be deployed via the HealthEdge Cloud or on-premises. This platform encompasses various functionalities, including claims and benefits administration, care management, and business intelligence, enabling clients to adopt new business models and streamline processes within the healthcare delivery system. In 2012, HealthEdge expanded its offerings by acquiring Click4Care, which enhanced its capabilities in clinical care management. Headquartered in Burlington, Massachusetts, HealthEdge also has a research and development center in Powell, Ohio.

Intelerad Medical Systems

Private Equity Round in 2020
Intelerad Medical Systems specializes in providing comprehensive medical imaging solutions and services tailored for radiology groups, hospitals, imaging centers, and teleradiology practices. The company's platform is designed to support clinicians and healthcare organizations worldwide by enhancing productivity and optimizing workflows in medical imaging. Intelerad's software focuses on distributed radiology services and incorporates various modules for workflow orchestration, allowing clients to efficiently manage their imaging processes. By streamlining operations, Intelerad assists healthcare providers in delivering better patient care and improving overall operational efficiency.

CorEvitas

Private Equity Round in 2019
CorEvitas is a provider of clinical registry data and analytics services focused on the biopharmaceutical sector. Established in 2000 and headquartered in Waltham, Massachusetts, the company specializes in delivering real-world evidence through its extensive registry data, which includes insights on patient experiences and outcomes. CorEvitas operates six autoimmune registries across the United States, Canada, and Japan, collecting data from over 400 participating investigator sites. The company ensures the accuracy and completeness of its data through rigorous quality control processes before it is stored in a secure data warehouse. Additionally, CorEvitas conducts active safety surveillance to support regulatory commitments for new drug approvals, contributing to post-authorization safety studies. The company's mission is to advance patient care and improve treatment through comprehensive real-world data analysis.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.